ArticleEClinicalMedicine2026
Burden of non-communicable diseases among adolescents and young adults aged 10-24 years in Middle East and North Africa, 1990-2023: a systematic analysis of the Global Burden of Diseases Study 2023.
Article in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-communicable diseases (NCDs) are a major contributor to morbidity and mortality worldwide, yet their burden among adolescents and young adults in the Middle East and North Africa (MENA) region remains underexplored. Understanding age-, sex-, and country-specific patterns is critical in a region marked by conflict, demographic transition, and rapid urbanization. Methods: We used estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 to quantify mortality and disability due to NCDs among people aged 10-24 years across 21 MENA countries from 1990 to 2023. Causes were analyzed by three hierarchical levels of the GBD 2023 cause list. For each cause, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) with 95% uncertainty intervals (UIs) were extracted and stratified by sex, age group, and country. Temporal trends (1990-2023) and associations between Level 2 NCD DALY rates and each country's Socio-demographic Index (SDI) were assessed using correlation. Analyses were performed using R (version 2025.09.0) and Julia (version 1.10). Findings: In 2023, NCDs accounted for 76.0% (95% UI 71.5-79.6) of all YLDs and 29.0% (27.0-32.3) of total deaths among young people aged 10-24 years in MENA. Among NCDs, cardiovascular diseases and neoplasms were the leading causes of mortality (9.64 [7.64-12.14] and 6.93 [6.05-7.78] per 100,000, respectively), whereas mental disorders were the main contributors to YLDs (2916.2 [2013.4-4165.8] per 100,000) and DALYs (2916.3 [2013.4-4165.9] per 100,000). NCD mortality was higher in males than females (37.9 vs 18.6 per 100,000), while females had slightly higher DALY rates (8970.4 vs 8221.6 per 100,000). From 1990 to 2023, mortality due to NCDs declined by 33.6% and YLLs by 34.2%, reflecting steady improvements until 2019 before plateauing during and after the COVID-19 period. Over the same timeframe, YLDs declined modestly until 2019 but increased thereafter (+8.6% [-3.4 to 21.9]), largely due to mental and metabolic disorders. The largest declines were seen for digestive (-60.9%) and cardiovascular diseases (-43.6%), whereas increases occurred in mental (128.4%) and substance-use disorders (12.9%). Countries with higher SDI scores had lower DALY rates for cardiovascular, digestive, neoplastic, and other NCDs. Interpretation: Integrated, youth-responsive NCD and mental health services are needed to address rising disability and health loss among young people in the MENA region. Funding: Khalifa University of Science and Technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.